Pentoxifylline
규격
6493-05-6CAS 번호
229-374-5EC 번호
3,7-dimethyl-1-(5-oxohexyl)purine-2,6-dioneIUPAC 명칭
C13H18N4O3화학식
278.31 g/mol분자량
pentoxifylline; 6493-05-6; Trental; Oxpentifylline; Pentoxil; Pentoxyphylline; Pentoxiphyllin; 1H-Purine-2,6-dione, 3,7-dihydro-3,7-dimethyl-1-(5-oxohexyl)-; 3,7-Dihydro-3,7-dimethyl-1-(5-oxohexyl)-1H-purine-2,6-dione; 1-(5-Oxohexyl)theobromine; BL 191; BL-191; Pentoxifilina; Oxypentifylline; Pentoxifyllinum; DTXSID7023437; SD6QCT3TSU; NSC637086; 3,7-dimethyl-1-(5-oxohexyl)-2,3,6,7-tetrahydro-1H-purine-2,6-dione; NSC-637086; NSC-758481; 1,2,3,6-Tetrahydro-3,7-dimethyl-1-(5-oxohexyl)-2,6-purindion; C04AD03; DTXCID803437; BL191; pentoxifillina; Neotren mr; Trental 100; Trental 400; RefChem:57078; 229-374-5; Pentoxifyllin; Torental; Vazofirin; 3,7-Dimethyl-1-(5-oxohexyl)xanthine; Dimethyloxohexylxanthine; Pentoxiphyllium; Pentoxyfylline; Pentoxiphylline; Rentylin; 3,7-dimethyl-1-(5-oxohexyl)purine-2,6-dione; 3,7-dimethyl-1-(5-oxohexyl)-1H-purine-2,6(3H,7H)-dione; Pentoxyphyllin; 3,7-Dimethyl-1-(5-oxohexyl)-3,7-dihydro-1H-purine-2,6-dione; Pentoxyfilline; Pentoxyifylline; 1-(5-Oxohexyl)-3,7-dimethylxanthine; MFCD00063379; Theobromine, 1-(5-oxohexyl)-; CHEMBL628; NSC 637086; 3,7-Dimethyl-1-(5-oxohexyl)-1H,3H-purin-2,6-dione; MLS000079026; Azupentat; EHT 0202; NCGC00015801-02; Durapental; SMR000035998; PNX; Hemovas; Ralofect; Vasofirin; Ikomio; Agapurin Retard; Pentoxifilina [INN-Spanish]; Pentoxifyllinum [INN-Latin]; Pentoxil (TN); Trental (TN); CAS-6493-05-6; EHT0201; SR-01000075641; 3,7-Dimethyl-1-(5-oxohexyl)xantine; 3,7-Dimethyl-1-(5-oxohexyl) xantine; Pentopak; Azupentat;; CCRIS 6832; Pentoflux;; Agapurin;; Torental;; Pentoxifylline (JAN/USP/INN); 3arr; 3aru; 3tvx; EHT-201; Pentoxifylline CRS; PTX;Oxpentifylline; EHT-0201; Prestwick_608; EINECS 229-374-5; PTXF; BRN 0558929; Spectrum_001444; 2a3c; UNII-SD6QCT3TSU; Opera_ID_1800; Prestwick0_000196; Prestwick1_000196; Prestwick2_000196; Prestwick3_000196; Spectrum2_001181; Spectrum3_001820; Spectrum4_000227; Spectrum5_001161; Lopac-P-1784; Pentoxifylline (Standard); P 1784; PENTOXIFYLLINE [MI]; PENTOXIFYLLINE [INN]; PENTOXIFYLLINE [JAN]; Lopac0_000936; SCHEMBL34039; 1-(5-Oxohexyl)-theobromine; BSPBio_000151; BSPBio_003439; KBioGR_000893; KBioSS_001924; PENTOXIFYLLINE [USAN]; MLS000758298; MLS001201764; MLS001424051; BIDD:GT0174; DivK1c_000729; PENTOXIFYLLINE [VANDF]; SPECTRUM1503611; SPBio_001221; SPBio_002072; PENTOXIFYLLINE [MART.]; BPBio1_000167; CHEBI:7986; GTPL7095; orb1224349; orb1310971; PENTOXIFYLLINE [USP-RS]; PENTOXIFYLLINE [WHO-DD]; BDBM10850; HMS502E11; HY-B0715R; KBio1_000729; KBio2_001924; KBio2_004492; KBio2_007060; KBio3_002942; MSK9064; NINDS_000729; GLXC-15427; HMS1568H13; HMS1922E16; HMS2051N06; HMS2090H13; HMS2093G21; HMS2095H13; HMS2235C16; HMS3262L14; HMS3370D09; HMS3393N06; HMS3712H13; HMS5083E13; Pharmakon1600-01503611; Pentoxifylline - Bio-X trade mark; HY-B0715; PENTOXIFYLLINE [ORANGE BOOK]; Tox21_110223; Tox21_500936; BBL016497; CCG-36382; EBC-12154; NSC758481; PDSP1_001015; PDSP2_000999; PENTOXIFYLLINE [EP MONOGRAPH]; STK177321; PENTOXIFYLLINE [USP MONOGRAPH]; AKOS000541484; Tox21_110223_1; AC-8381; DB00806; FP26823; LP00936; NC00255; SDCCGSBI-0050910.P004; 3,7-dimethyl-1-(5-oxohexyl)-xanthine; CAS-1677687; IDI1_000729; NCGC00015801-01; NCGC00015801-03; NCGC00015801-04; NCGC00015801-05; NCGC00015801-06; NCGC00015801-07; NCGC00015801-08; NCGC00015801-09; NCGC00015801-10; NCGC00015801-12; NCGC00015801-15; NCGC00015801-17; NCGC00015801-21; NCGC00067069-02; NCGC00067069-03; NCGC00067069-04; NCGC00067069-05; NCGC00178062-01; NCGC00178062-02; NCGC00261621-01; AS-13662; BP166188; Pentoxifylline [USAN:USP:INN:BAN:JAN]; SY055216; SBI-0050910.P003; 1-(5-oxohexyl)theobromine (pentoxifylline); AB00052363; EU-0100936; NS00010010; P2050; S4345; ST50242554; SW196777-4; C07424; D00501; D70138; M02258; AB00052363-17; AB00052363_18; AB00052363_21; 5-26-14-00081 (Beilstein Handbook Reference); EN300-18527828; Q416331; 3,7-dimethyl-1-(5-oxohexyl)-1H-purine-2,6-dione; SR-01000075641-1; SR-01000075641-4; SR-01000075641-7; SR-01000075641-9; BRD-K57569181-001-05-1; BRD-K57569181-001-16-8; BRD-K57569181-001-26-7; BRD-K57569181-001-27-5; Z1741982628; 3,7-dimethyl-1-(5-oxohexyl)-3,7-dihydropurine-2,6-dione; 3,7-dimethyl-1-(5-oxohexyl)-1,3,7-trihydropurine-2,6-dione; 3,7-Dimethyl-1-(5-oxohexyl)-3,7-dihydro-1H-purine-2,6-dione #; Px동의어
Pentoxifylline 함유 제품
씨엠지펜톡시필린서방정400mg(펜톡시필린)명인펜톡시필린서방정(펜톡시필린)(수출용)메조톡실주(펜톡시필린)(수출용)카펜탈주(펜톡시필린)(수출용)트렌탈서방정400(펜톡시필린)PENTOXIFILINA VIR 400 mg COMPRIMIDOS DE LIBERACION PROLONGADA EFGPENTOXIFILINA SEJMET 400 mg COMPRIMIDOS DE LIBERACION PROLONGADA EFGPENTOXIFILINA ALTER 400 mg COMPRIMIDOS DE LIBERACION PROLONGADA EFGHEMOVAS 600 MG COMPRIMIDOS DE LIBERACION PROLONGADAHEMOVAS 400 MG COMPRIMIDOS DE LIBERACION PROLONGADAHEMOVAS 300 MG SOLUCION PARA PERFUSIONELORGAN 400 mg COMPRIMIDOS DE LIBERACION PROLONGADA
1/3 페이지
Pentoxifylline 판매 기업
1/3 페이지